Abstract
This column originated with a vignette told by a former resident. The case illustrates the importance of understanding the concept of potency and relative potency and provides a clinical illustration of a number of theoretical points discussed in earlier columns.1-3 It also provides another example of the clinical relevance of the following equation: The vignette involved a patient who was admitted when the former resident was on call more than a decade ago. For this reason, the case involved older drugs but the pharmacological principles remain clinically relevant today. A 30-year-old psychotic patient was in the process of being admitted from the emergency room to the university inpatient service at night. The in-house physician was in his second year of residency training. Based on the report from the emergency room, the patient was large, agitated, and combative. The nursing staff was concerned and hence asked the resident for intramuscular (IM) medication orders to help calm the patient rapidly and reliably. Uncertain as to the best course of action, the resident called the attending physician to discuss options. This case occurred before the introduction of the new third generation "atypical" antipsychotics and so the options discussed were haloperidol (the most widely used second generation "high-potency" antipsychotic of that era), benzodiazepines, and first generation "low-potency" antipsychotics. Benzodiazepines were ruled out because of the patient's level of agitation. He had been physically acting out and had been placed in four-point restraints. It was therefore decided that benzodiazepines should not be used because they can lower behavioral inhibition before sedating a person and could increase the potential for acting out. The discussion thus centered on whether to use haloperidol (Haldol) or chlorpromazine (Thorazine). Given the patient's profound agitation, the attending physician suggested chlorpromazine rather than haloperidol. Although the resident was not familiar with the use of chlorpromazine, he readily concurred with the suggestion. After the conversation ended, the resident realized that he had not made the attending physician aware that he was not familiar with this use of chlorpromazine and did not know what dose to use. Nevertheless, the resident was familiar with the use of haloperidol for the treatment of agitated patients and believed that he understood the concept of relative potency. In fact, he had an article that gave him the relative potency of haloperidol (a "high potency" antipsychotic) versus chlorpromazine (a "low potency" antipsychotic) as well as the usual p.r.n. ("as needed") dosing for haloperidol for agitation. His reference article indicated that 2 mg of haloperidol were equivalent to 100 mg of chlorpromazine. The usual p.r.n. haloperidol orders for such situations recommended 2.0-5.0 mg IM. Based on his reference paper, the resident thus concluded that the equivalent dose of chlorpromazine would be between 100 and 250 mg IM. However, the patient was quite large. The resident therefore considered the issue of volume of distribution (an example of one of the biological variance factors in the third variable in equation 1 above) and concluded that he would normally have used a large dose of haloperidol-perhaps 10 mg IM. Hence, the equivalent amount of chlorpromazine would be 500 mg IM. However, this sounded like a high dose to the resident, so he decided to split the difference and go with 350 mg IM of chlorpromazine. Thus was the stage set for potential disaster.